BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25454690)

  • 1. Detection of breast cancer in an FDG-PET cancer screening program: results of a nationwide Japanese survey.
    Minamimoto R; Senda M; Jinnouchi S; Terauchi T; Yoshida T; Inoue T
    Clin Breast Cancer; 2015 Apr; 15(2):e139-46. PubMed ID: 25454690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of thyroid cancer by an FDG-PET cancer screening program: a Japanese nation-wide survey.
    Minamimoto R; Senda M; Jinnouchi S; Terauchi T; Yoshida T; Inoue T
    Anticancer Res; 2014 Aug; 34(8):4439-45. PubMed ID: 25075083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of colorectal cancer and adenomas by FDG-PET cancer screening program: results based on a nationwide Japanese survey.
    Minamimoto R; Senda M; Jinnouchi S; Terauchi T; Yoshida T; Inoue T
    Ann Nucl Med; 2014 Apr; 28(3):212-9. PubMed ID: 24347363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of various malignant neoplasms detected by FDG-PET cancer screening program: based on a Japanese Nationwide Survey.
    Minamimoto R; Senda M; Terauchi T; Jinnouchi S; Inoue T; Iinuma T; Inoue T; Ito K; Iwata H; Uno K; Oku S; Oguchi K; Tsukamoto E; Nakashima R; Nishizawa S; Fukuda H; Murano T; Yoshida T
    Ann Nucl Med; 2011 Jan; 25(1):45-54. PubMed ID: 20953985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance profile of FDG-PET and PET/CT for cancer screening on the basis of a Japanese Nationwide Survey.
    Minamimoto R; Senda M; Uno K; Jinnouchi S; Iinuma T; Ito K; Okuyama C; Oguchi K; Kawamoto M; Suzuki Y; Tsukamoto E; Terauchi T; Nakashima R; Nishio M; Nishizawa S; Fukuda H; Yoshida T; Inoue T
    Ann Nucl Med; 2007 Nov; 21(9):481-98. PubMed ID: 18030580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of fluorodeoxyglucose-positron emission tomography/computed tomography combined with ultrasonography-guided fine needle aspiration cytology for identifying axillary lymph node status in patients with breast cancer.
    Machida Y; Kubota K; Katayama T; Toriihara A; Shibuya H
    Eur J Surg Oncol; 2013 Jan; 39(1):26-30. PubMed ID: 23122913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance profile of a FDG-PET cancer screening program for detecting gastric cancer: results from a nationwide Japanese survey.
    Minamimoto R; Senda M; Jinnouchi S; Terauchi T; Yoshida T; Inoue T
    Jpn J Radiol; 2014 May; 32(5):253-9. PubMed ID: 24562822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The current status of an FDG-PET cancer screening program in Japan, based on a 4-year (2006-2009) nationwide survey.
    Minamimoto R; Senda M; Jinnouchi S; Terauchi T; Yoshida T; Murano T; Fukuda H; Iinuma T; Uno K; Nishizawa S; Tsukamoto E; Iwata H; Inoue T; Oguchi K; Nakashima R; Inoue T
    Ann Nucl Med; 2013 Jan; 27(1):46-57. PubMed ID: 23086544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDG-PET/CT detection of very early breast cancer in women with breast microcalcification lesions found in mammography screening.
    Peng NJ; Chou CP; Pan HB; Chang TH; Hu C; Chiu YL; Fu TY; Chang HT
    J Med Imaging Radiat Oncol; 2015 Aug; 59(4):445-452. PubMed ID: 25872026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of (18)F-FDG PET/CT in the diagnosis of breast cancer and lymph nodes metastases and micrometastases may be limited.
    Zhang X; Wu F; Han P
    Hell J Nucl Med; 2014; 17(3):177-83. PubMed ID: 25526754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer staging in a single session: whole-body PET/CT mammography.
    Heusner TA; Kuemmel S; Umutlu L; Koeninger A; Freudenberg LS; Hauth EA; Kimmig KR; Forsting M; Bockisch A; Antoch G
    J Nucl Med; 2008 Aug; 49(8):1215-22. PubMed ID: 18632831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical roles of breast 3T MRI, FDG PET/CT, and breast ultrasound for asymptomatic women with an abnormal screening mammogram.
    Chou CP; Peng NJ; Chang TH; Yang TL; Hu C; Lin HS; Huang JS; Pan HB
    J Chin Med Assoc; 2015 Dec; 78(12):719-25. PubMed ID: 26364959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preliminary report of breast cancer screening by positron emission mammography.
    Yamamoto Y; Tasaki Y; Kuwada Y; Ozawa Y; Inoue T
    Ann Nucl Med; 2016 Feb; 30(2):130-7. PubMed ID: 26586370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
    Chang HT; Hu C; Chiu YL; Peng NJ; Liu RS
    PLoS One; 2014; 9(12):e115127. PubMed ID: 25517451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
    Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
    Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of lung cancer by FDG-PET cancer screening program: a nationwide Japanese survey.
    Minamimoto R; Senda M; Jinnouchi S; Terauchi T; Yoshida T; Uno K; Iinuma T; Murano T; Nakashima R; Inoue T
    Anticancer Res; 2014 Jan; 34(1):183-9. PubMed ID: 24403460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-FDG PET/CT and PET for evaluation of pathological response to neoadjuvant chemotherapy in breast cancer: a meta-analysis.
    Cheng X; Li Y; Liu B; Xu Z; Bao L; Wang J
    Acta Radiol; 2012 Jul; 53(6):615-27. PubMed ID: 22734080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammography and ultrasonography evaluation of unexpected focal 18F-FDG uptakes in breast on PET/CT.
    Kim MY; Cho N; Chang JM; Yun BL; Bae MS; Kang KW; Moon WK
    Acta Radiol; 2012 Apr; 53(3):249-54. PubMed ID: 22262866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
    Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G
    Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Performance profile of FDG-PET and PET/CT for cancer screening based on a Japanese nationwide survey].
    Minamimoto R; Senda M; Uno K; Jinnouchi S; Iinuma T; Ito K; Okuyama C; Oguchi K; Kawamoto M; Suzuki Y; Tsukamoto E; Terauchi T; Nakashima R; Nishio M; Nishizawa S; Fukuda H; Yoshida T; Inoue T
    Kaku Igaku; 2007 May; 44(2):105-24. PubMed ID: 18240583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.